Security key
92859E207
Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (VVOS)
CUSIP: 92859E207
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 686,727
- Total 13F value
- $2,129,135
- Share change
- +282,280
- SEC-reported price per share
- $3.10
- Number of holders
- 22
- Value change
- +$875,070
- Number of buys
- 11
- Number of sells
- 8
- Shares outstanding
- 13,985,437
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
22
Top holders
10
VVOS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Vivos Therapeutics, Inc. SEC filings
Vivos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92859E207
Recent filing periods:
Ownership snapshot
Top reported holders of VVOS - Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
V-CO Investors LLC
Disclosed value leader
V-CO Investors LLC
Comparable rows
15/15
Latest evidence
08 Jul 2025
13D/G
13F
Lead comparable stake: 20%
13D/G row: V-CO Investors LLC
Showing 1-6 of 15 holder rows.
Quick read
V-CO Investors LLC leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens V-CO Investors LLC's linked filing trail.
Comparable ownership
Top 5
V-CO Investors LLC
20%
Dawei Luo
8.5%
INTRACOASTAL CAPITAL, LLC
5%
UBS Group AG
1%
B. Riley Wealth Advisors, Inc.
0.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| V-CO Investors LLC |
13D/G
SP Manager LLC
|
20%
|
$4,188,594
1,342,498 shares
|
+$2,583,360 | 09 Jun 2025 |
| Dawei Luo |
13D/G
|
8.5%
|
$3,432,096
572,016 shares
|
$0 | 08 Jul 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$796,804
297,315 shares
|
$0 | 22 Dec 2024 |
| UBS Group AG |
13F
Company
|
1%
|
$451,251
142,801 shares
|
— | 30 Jun 2025 |
| B. Riley Wealth Advisors, Inc. |
13F
Company
|
0.5%
|
$219,718
69,531 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.41%
|
$182,970
57,902 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
686,727
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q1 2026 Across Filers
Q1 2026 holders
23
Q3 2025 holders
22
Holder diff
-1
| Investor | Q1 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend